Data Sciences International

Data Sciences International

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $14.5M

Overview

Data Sciences International (DSI) is a mission-critical infrastructure provider for the preclinical life sciences sector, specializing in high-fidelity physiologic monitoring systems for laboratory animals. Founded in 1980, the company has established an authoritative track record with its technology cited in over 16,000 publications and used to monitor more than 750,000 research subjects. Its strategy focuses on integrated hardware and software platforms that enable stress-free, continuous data collection, thereby enhancing research quality and efficiency. DSI operates as a key, revenue-generating subsidiary of Harvard Bioscience, serving a global customer base.

CardiovascularRespiratoryNeuroscienceMetabolic DiseaseSafety Pharmacology

Technology Platform

Integrated platform for preclinical physiologic monitoring, featuring implantable and external telemetry, respiratory/inhalation systems (Buxco), and specialized software suites (FinePointe, NeuroScore, Data Insights) for continuous, high-fidelity data acquisition and analysis.

Funding History

2
Total raised:$14.5M
Series A$12M
Seed$2.5M

Opportunities

Growth is driven by the global push for more predictive preclinical data and ethical animal research (New Approach Methodologies), creating demand for DSI's welfare-enhancing platforms like SoHo telemetry and SmartStudy.
Expansion into high-margin software analytics (Data Insights) and integrated neuroscience solutions offers significant upside.

Risk Factors

Revenue is cyclical and tied to biopharma R&D spending.
Technological disruption from new monitoring modalities and evolving regulatory standards for animal research pose long-term threats.
As a subsidiary, strategic direction depends on parent company priorities.

Competitive Landscape

DSI holds a dominant position in integrated preclinical telemetry, competing with specialists like emka TECHNOLOGIES and ADInstruments. Its key advantages are unparalleled scientific validation (16,000+ citations), a full-spectrum platform, and a large global installed base, creating high switching costs for customers.